Patents by Inventor Jonathan David BEADLE

Jonathan David BEADLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12337038
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: June 24, 2025
    Inventors: Akbar Husain Khan, Andreas Lothar Severino Maderna, Maximillian Taro William Lee, Mattia Cocco, Boliang Deng, Jonathan David Beadle, Albano Galan Coca, Alla Pryyma, Nicole Danielle Bartolo, Luke Masterson, William Robert Fraser Goundry
  • Publication number: 20250073339
    Abstract: The specification relates to conjugates comprising a linker of Formula (IMA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: August 14, 2024
    Publication date: March 6, 2025
    Inventors: Jonathan David BEADLE, Albano GALAN COCA, Mattia COCCO, William Robert Fraser GOUNDRY
  • Publication number: 20250057969
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: August 14, 2024
    Publication date: February 20, 2025
    Inventors: Jonathan David BEADLE, Albano GALAN COCA, Mattia COCCO, William Robert Fraser GOUNDRY
  • Publication number: 20240366781
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: April 9, 2024
    Publication date: November 7, 2024
    Inventors: Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Mattia COCCO, Boliang DENG, Jonathan David BEADLE, Albano GALAN COCA, Alla PRYYMA, Nicole Danielle BARTOLO, Luke MASTERSON, William Robert Fraser GOUNDRY